Veradigm Inc (MDRX)
7.96
+0.01
(+0.13%)
USD |
OTCM |
Apr 26, 15:59
Veradigm SG&A Expense (Quarterly): 32.52M for Sept. 30, 2022
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
September 30, 2022 | 32.52M |
June 30, 2022 | 59.85M |
March 31, 2022 | 41.32M |
December 31, 2021 | 226.13M |
September 30, 2021 | 27.39M |
June 30, 2021 | 28.12M |
March 31, 2021 | 32.16M |
December 31, 2020 | 93.78M |
September 30, 2020 | 93.44M |
June 30, 2020 | 109.90M |
March 31, 2020 | 92.82M |
December 31, 2019 | 93.87M |
September 30, 2019 | 101.15M |
June 30, 2019 | 105.54M |
March 31, 2019 | 100.24M |
December 31, 2018 | 81.87M |
September 30, 2018 | 108.12M |
June 30, 2018 | 122.91M |
March 31, 2018 | 119.94M |
December 31, 2017 | 60.45M |
September 30, 2017 | 117.35M |
June 30, 2017 | 112.04M |
March 31, 2017 | 110.84M |
December 31, 2016 | 56.79M |
September 30, 2016 | 98.78M |
Date | Value |
---|---|
June 30, 2016 | 94.80M |
March 31, 2016 | 84.15M |
December 31, 2015 | 79.35M |
September 30, 2015 | 91.04M |
June 30, 2015 | 86.75M |
March 31, 2015 | 82.03M |
December 31, 2014 | 85.04M |
September 30, 2014 | 97.03M |
June 30, 2014 | 86.66M |
March 31, 2014 | 89.95M |
December 31, 2013 | 109.27M |
September 30, 2013 | 104.51M |
June 30, 2013 | 101.59M |
March 31, 2013 | 104.23M |
December 31, 2012 | 104.35M |
September 30, 2012 | 90.41M |
June 30, 2012 | 92.29M |
March 31, 2012 | 97.32M |
December 31, 2011 | 89.74M |
September 30, 2011 | 92.15M |
June 30, 2011 | 101.53M |
March 31, 2011 | 104.15M |
September 30, 2010 | 103.83M |
May 31, 2010 | 61.74M |
February 28, 2010 | 54.67M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
27.39M
Minimum
Sep 2021
226.13M
Maximum
Dec 2021
81.29M
Average
93.13M
Median
SG&A Expense (Quarterly) Benchmarks
LifeMD Inc | 35.96M |
TruBridge Inc | 27.82M |
Streamline Health Solutions Inc | 4.122M |
PetMed Express Inc | 19.19M |
LENZ Therapeutics Inc | -- |